Methods for Producing Rebaudioside D and Rebaudioside M

The use of glycosyltransferases UGT-B and UGT-A to convert rebaudioside A into rebaudioside D and M addresses the inefficiencies of conventional methods, enabling cost-effective and high-yield production of these sweeteners.

JP2024540897AInactive Publication Date: 2024-11-06CJ CHEILJEDANG CORP
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2024523245
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-10-19
Filing Date
2022-10-18
Publication Date
2024-11-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Conventional methods for producing rebaudioside D and rebaudioside M from stevia leaves are costly and inefficient due to their low abundance and high bitterness, limiting their use as alternative sweeteners.

Method used

A method involving glycosyltransferases, specifically UGT-B and UGT-A, is used to convert rebaudioside A into rebaudioside D and M by reacting it with glucose-bound nucleotide diphosphates in a continuous reaction system, utilizing enzymes derived from recombinant organisms or commercially available forms.

Benefits of technology

This method achieves high-purity and high-yield production of rebaudioside D and M with minimal byproducts, using inexpensive raw materials and a simple process suitable for mass production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024540897000001_ABST
    Figure 2024540897000001_ABST
Patent Text Reader

Abstract

The present application relates to a method for producing rebaudioside D and rebaudioside M by a glycosyltransferase reaction, and a composition for producing rebaudioside D and rebaudioside M, which contains glycosyltransferase.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present application relates to a method for producing rebaudioside D and rebaudioside M by a glycosyltransferase reaction, and a composition for producing rebaudioside D and rebaudioside M, which contains glycosyltransferase. [Background technology]

[0002] The World Health Organization (WHO) has recommended reducing daily sugar intake due to the risk of diseases (obesity) caused by sugar intake, and various government-led policies to reduce sugar intake are being actively discussed, mainly in developed countries. In addition, there is an increasing need in the market for various alternative sweetener materials to replace sugar and high fructose, and the development and commercialization of alternative sweetener materials continues.

[0003] Alternative sweeteners have been changing from synthetic sweeteners (saccharin, aspartame, sucralose, etc.), synthetic sugar alcohols (maltitol, xylitol), to high sweeteners (rebaudioside A, liquorice). However, although consumers' needs for natural sweeteners are growing due to concerns about the long-term stability of synthetic sweeteners, natural sweeteners have limitations in terms of taste quality, including strange tastes and odors, and so they have not been able to fully replace traditional synthetic sweetener-based low-calorie and zero-calorie products.

[0004] In this regard, a natural high-sweetener that has attracted much attention in recent years is stevia sweetener extracted from stevia leaves. It has been reported that stevia sweetener has no calories, has beneficial effects on blood glucose and insulin levels, and has no side effects on the human body, and has potential as an alternative sweetener, but has the disadvantage of being very bitter, which limits its use in reducing sugar.

[0005] Stevia is a perennial plant of the Asteraceae family native to Paraguay in South America, and its scientific name is Stevia rebaudiana Bertoni. Stevia leaves contain components that are 200 to 300 times sweeter than sugar, so these sweet components are extracted and used as natural sweeteners. The sweet components of stevia extract include various steviol glycosides such as stevioside, rebaudioside A, rebaudioside C, rebaudioside D, rebaudioside M, rebaudioside I, and rebaudioside E.

[0006] Among the sweetening components of stevia extract, stevioside (STV), rebaudioside A (Reb A), and rebaudioside C (Reb C) are found in relatively high amounts in stevia leaves and are extracted and refined at high purity for industrialization and commercialization. However, they have the drawback of being very bitter, limiting their use in reducing sugar intake.

[0007] On the other hand, rebaudioside D (Reb D) and rebaudioside M (Reb M) have less bitterness and excellent sweetness quality compared to STV, rebaudioside A, and rebaudioside C, and are therefore valuable as alternative sweeteners. However, rebaudioside D and rebaudioside M are present in extremely small amounts in stevia leaves, and the method of extracting and purifying them from the leaves and producing them is disadvantageous in that it requires high costs. [Prior art documents] [Patent documents]

[0008] [Patent Document 1] Korean Patent No. 1404728 [Patent Document 2] International Publication No. 2014 / 133248 [Non-patent literature]

[0009] [Non-Patent Document 1] Pearson et al (1988) [Proc. Natl. Acad. Sci. USA 85]: 2444 [Non-licensed document 2] Rice et al., 2000, Trends Genet. 16: 276-277 [Non-licensed document 3] Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453

Non-licensed Document 4

Non-licensed Document 5

Non-licensed Document 6

Non-licensed Document 7

Non-licensed Document 8

Non-licensed literature 9

Non-licensed literature 10

Non-licensed Document 11

[0010] The present applicant has conducted intensive research to develop an enzyme having the activity of converting rebaudioside A to rebaudioside D, and as a result has found that a polypeptide sequence, the glycosyltransferase activity of which has not been disclosed in the past, has glycosyltransferase activity, and confirmed that the polypeptide has the glycosyltransferase activity of converting rebaudioside A to rebaudioside D, thereby completing the present application. [Means for solving the problem]

[0011] An object of the present application is to provide a method for producing rebaudioside D, comprising the step of reacting a glucose-bound nucleotide diphosphate with rebaudioside A in the presence of glycosyltransferase B (UGT-B), which is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3, to produce rebaudioside D.

[0012] Another object of the present application is to provide a method for producing rebaudioside M, comprising the steps of reacting a glucose-bound nucleotide diphosphate with rebaudioside A in the presence of glycosyltransferase B (UGT-B) to produce rebaudioside D, and reacting the rebaudioside D with a glucose-bound nucleotide diphosphate in the presence of glycosyltransferase A (UGT-A) to produce rebaudioside M, wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

[0013] Furthermore, the present application aims to provide a method for producing rebaudioside D from rebaudioside A, comprising the step of reacting sucrose, nucleotide diphosphate, rebaudioside A, sucrose synthase, and glycosyltransferase B (UGT-B) in a single reaction system to produce rebaudioside D.

[0014] Furthermore, the present application aims to provide a method for producing rebaudioside M from rebaudioside A, comprising the step of reacting sucrose, nucleotide diphosphate, rebaudioside A, rebaudioside D, sucrose synthase, glycosyltransferase A (UGT-A), and glycosyltransferase B (UGT-B) in a single reaction system to produce rebaudioside M.

[0015] A further object of the present application is to provide a composition for producing rebaudioside D, comprising the glycosyltransferase B (UGT-B).

[0016] Furthermore, an object of the present application is to provide a composition for producing rebaudioside M, comprising glycosyltransferase A (UGT-A) and glycosyltransferase B (UGT-B).

[0017] Furthermore, an object of the present application is to provide use of glycosyltransferase B (UGT-B), which is at least one protein selected from the group consisting of proteins having the amino acid sequences shown in SEQ ID NOs: 1 to 3, as a glycosyltransferase that converts rebaudioside A to rebaudioside D. Effect of the Invention

[0018] The method for producing rebaudioside D and rebaudioside M using glycosyltransferase B (UGT-B) according to the present application can provide rebaudioside D and rebaudioside M in high purity and high yield with almost no by-products, is economical since it uses inexpensive raw materials, has a simple procedure with little time consumption, and is useful for mass production of rebaudioside D and rebaudioside M. [Brief description of the drawings]

[0019] [Figure 1] FIG. 1 is an HPLC analysis result showing that rebaudioside A is converted to rebaudioside D by glycosyltransferase B (UGT-B_6). [Diagram 2] 1 is an HPLC analysis showing that rebaudioside A is converted to rebaudioside D, rebaudioside D isomers, and rebaudioside M isomers by glycosyltransferase B (UGT-B_7). [Diagram 3] FIG. 1 is an HPLC analysis result showing that rebaudioside A is converted to rebaudioside D by glycosyltransferase B (UGT-B_8). [Figure 4] 1 is an HPLC analysis result showing the production of rebaudioside D, rebaudioside M, rebaudioside I, and rebaudioside A from stevioside by glycosyltransferase B (UGT-B_6), glycosyltransferase A (UGT-A), and sucrose synthase. [Diagram 5] 1 is an HPLC analysis result showing that rebaudioside M isomer, rebaudioside D, rebaudioside M, rebaudioside I, and rebaudioside A are produced from stevioside by glycosyltransferase B (UGT-B_7), glycosyltransferase A (UGT-A), and sucrose synthase. [Figure 6]1 is an HPLC analysis result showing the production of rebaudioside D, rebaudioside M, rebaudioside I, and rebaudioside A from stevioside by glycosyltransferase B (UGT-B_8), glycosyltransferase A (UGT-A), and sucrose synthase. [Figure 7] 1 is an HPLC analysis showing the conversion of Rebaudioside D to Rebaudioside M by glycosyltransferase A (UGT-A). [Figure 8] 1 shows the results of LC-MS / MS analysis of rebaudioside D isomers. [Figure 9] LC-MS / MS analysis results of rebaudioside D. [Figure 10] 1 shows the results of LC-MS / MS analysis of rebaudioside M isomers. [Figure 11] LC-MS / MS analysis results of rebaudioside M. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0020] These will be described in detail below. Each description and embodiment disclosed in this application is also applicable to other descriptions and embodiments. That is, all combinations of various elements disclosed in this application are included in this application. In addition, this application is not limited to the following specific description. Furthermore, many papers and patent documents are referenced throughout this specification, and citations are provided. The disclosure contents of the cited papers and patent documents are incorporated in their entirety into this specification by reference, thereby more clearly explaining the state of the art to which this application pertains and the contents of this application.

[0021] One aspect of the present application provides a method for producing rebaudioside D, comprising the step of reacting a glucose-bound nucleotide diphosphate with rebaudioside A in the presence of glycosyltransferase B (UGT-B), which is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3, to produce rebaudioside D.

[0022] In the present application, "glycosyltransferase (UDP (Uridine diphosphate)-glycosyltransferase, UGT)" refers to an enzyme that has the activity of transferring a monosaccharide moiety from a glycosyl donor to a glycosyl acceptor molecule, specifically, an enzyme that uses a UDP-sugar as a glycosyl donor. In the present application, the glycosyltransferase is also referred to as "UDP-glycosyltransferase" and "UGT."

[0023] The glycosyltransferase may be produced from recombinant Escherichia coli, Bacillus, yeast, Corynebacterium or Agrobacterium transformed with a vector having a glycosyltransferase gene, produced from the Escherichia coli or the like and further purified, or may be purchased as a commercially available product, but is not limited to these. The glycosyltransferase is known in the art, and the protein and gene sequences of the glycosyltransferase can be obtained from known databases, for example, but not limited to, GenBank of NCBI.

[0024] In the present application, it has been discovered that glycosyltransferase B (UGT-B), which is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3, has the enzymatic activity of converting rebaudioside A to rebaudioside D, and a new use of UGT-B is provided.

[0025] Specifically, the glycosyltransferase B (UGT-B) of the present application may have the amino acid sequence shown in SEQ ID NO: 1, the amino acid sequence shown in SEQ ID NO: 2, or the amino acid sequence shown in SEQ ID NO: 3, may contain the amino acid sequence, may essentially consist of the amino acid sequence, or may consist of the amino acid sequence.

[0026] Furthermore, the glycosyltransferase B (UGT-B) of the present application may comprise an amino acid sequence having at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.5%, 99.7% or 99.9% homology or identity to the amino acid sequence shown in SEQ ID NO: 1, the amino acid sequence shown in SEQ ID NO: 2, or the amino acid sequence shown in SEQ ID NO: 3. Furthermore, it goes without saying that the glycosyltransferase B (UGT-B) having an amino acid sequence in which a portion of the sequence has been deleted, modified, substituted, conservatively substituted or added is also included in the present application, so long as the amino acid sequence has such homology or identity and exhibits an effect equivalent to that of the glycosyltransferase B (UGT-B) of the present application.

[0027] Even if the present application describes "a polypeptide or protein comprising an amino acid sequence represented by a specific SEQ ID NO," "a polypeptide or protein consisting of an amino acid sequence represented by a specific SEQ ID NO," or "a polypeptide or protein having an amino acid sequence represented by a specific SEQ ID NO," it goes without saying that any protein having an amino acid sequence in which a part of the sequence has been deleted, modified, substituted, conservatively substituted, or added is also used in the present application, so long as it has the same or corresponding activity as the polypeptide consisting of the amino acid sequence of the SEQ ID NO. For example, there are those having an addition of a sequence that does not change the function of the protein at the N-terminus and / or C-terminus of the amino acid sequence, a naturally occurring mutation, a silent mutation, or a conservative substitution thereof.

[0028] For example, the amino acid sequence may have an addition or deletion of a sequence that does not change the function of the glycosyltransferase B (UGT-B) of the present application, a naturally occurring mutation, a silent mutation, or a conservative substitution at the N-terminus, C-terminus, and / or internally.

[0029] In the present application, "conservative substitution" refers to the replacement of an amino acid with another amino acid having similar structural and / or chemical properties. Such amino acid substitutions may generally occur based on similarity in polarity, charge, solubility, hydrophobicity, hydrophilicity, and / or amphipathic nature of the residues. For example, positively charged (basic) amino acids include arginine, lysine, and histidine, negatively charged (acidic) amino acids include glutamic acid and aspartic acid, aromatic amino acids include phenylalanine, tryptophan, and tyrosine, and hydrophobic amino acids include alanine, valine, isoleucine, leucine, methionine, phenylalanine, tyrosine, and tryptophan. Amino acids are also classified into those with electrically charged side chains and those with uncharged side chains, with the charged side chains including aspartic acid, glutamic acid, lysine, arginine, and histidine, and the uncharged side chains are further classified into nonpolar and polar amino acids, with the nonpolar amino acids including glycine, alanine, valine, leucine, isoleucine, methionine, phenylalanine, tryptophan, and proline, and the polar amino acids including serine, threonine, cysteine, tyrosine, asparagine, and glutamine. Conservative substitutions usually have little or no effect on the activity of the resulting polypeptide. Conservative substitutions usually have little or no effect on the activity of a protein or polypeptide.

[0030] The UGT-B may also contain deletions or additions of amino acids that have minimal effect on the properties and secondary structure of the polypeptide. For example, the polypeptide may be linked to an N-terminal signal (or leader) sequence of a protein involved in co-translationally or post-translationally protein transfer. The polypeptide may also be linked to other sequences or linkers that allow the polypeptide to be identified, purified, or synthesized.

[0031] In this application, "homology" or "identity" refers to the degree of similarity between two given amino acid or nucleotide sequences, expressed as a percentage. Homology and identity are often used interchangeably.

[0032] Sequence homology or identity of conserved polynucleotides or polypeptides may be determined by standard sequence algorithms, with default gap penalties established by the program used. Substantially homologous or identical sequences will generally hybridize to the entire sequence or to a portion thereof under moderate or high stringent conditions. Hybridization, of course, also includes hybridization to polynucleotides having common codons or codons that take into account the degeneracy of codons in the polynucleotide.

[0033] Whether any two polynucleotide or polypeptide sequences have homology, similarity or identity can be determined using known computer algorithms such as the "FASTA" program with default parameters as in, for example, Non-Patent Document 1. Alternatively, it can be determined using the Needleman-Wunsch algorithm (Non-Patent Document 3), as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Non-Patent Document 2) (version 5.0.0 or later), which includes the GCG program package (Non-Patent Document 4), BLASTP, BLASTN, FASTA (Non-Patent Documents 5, 6 and 7). For example, BLAST or Clustal W from the National Center for Biotechnology Information can be used to determine homology, similarity or identity.

[0034] Homology, similarity or identity of polynucleotides or polypeptides can be determined by comparing sequence information using a GAP computer program such as that disclosed in Non-Patent Document 3, as disclosed in Non-Patent Document 8. In summary, the GAP program defines the number of similar sequence symbols (i.e., nucleotides or amino acids) divided by the total number of symbols in the shorter of the two sequences. Default parameters for the GAP program include (1) a binary comparison matrix (identity takes a value of 1 and non-identity takes a value of 0) and a weighted comparison matrix of Non-Patent Document 10 (or an EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution matrix) as disclosed in Non-Patent Document 9, (2) a penalty of 3.0 for each gap and an additional penalty of 0.10 for each symbol in each gap (or a gap open penalty of 10 and a gap extension penalty of 0.5), and (3) no penalty for terminal gaps.

[0035] As an example of the present application, the glycosyltransferase B (UGT-B) of the present application may have the activity of converting rebaudioside A to rebaudioside D.

[0036] "Corresponding to" in this application means the amino acid residue at the recited position in the polypeptide, or an amino acid residue similar, identical or homologous to the recited residue in the polypeptide. Identifying the amino acid at the corresponding position will determine the particular amino acid of the sequence to which the particular sequence is referenced. "Corresponding region" in this application generally refers to a similar or corresponding position in a related or reference protein.

[0037] For example, any amino acid sequence can be aligned with SEQ ID NO: 1, and based thereon, each amino acid residue of the amino acid sequence can be numbered with reference to the number and position of the amino acid residues corresponding to the amino acid residues in SEQ ID NO: 1. For example, the sequence alignment algorithm in the present application can identify the positions of amino acids or positions where modifications such as substitutions, insertions, deletions, etc. occur when compared to a query sequence (also referred to as a "reference sequence").

[0038] For such alignment, for example, the Needleman-Wunsch algorithm (Non-Patent Document 3) or the Needle program in the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Non-Patent Document 2) can be used, but is not limited to these. Sequence alignment programs and pairwise sequence comparison algorithms known in the technical field can be used as appropriate.

[0039] The polynucleotide encoding glycosyltransferase B (UGT-B) of the present application may be any nucleotide sequence that is not only a nucleotide sequence encoding the amino acids represented by each of the above SEQ ID NOs, but also a gene sequence that is 80% or more, preferably 90% or more, more preferably 95% or more, even more preferably 98% or more, and most preferably 99% or more homologous to the above sequences and that encodes a protein that exhibits substantially the same or corresponding efficacy as each of the above proteins. Needless to say, the present application also includes nucleotide sequences with such homology, in which a portion of the sequence has been deleted, modified, substituted, or added.

[0040] In the present application, the term "polynucleotide" refers to a nucleotide polymer in which nucleotide monomers are linked in a long chain by covalent bonds, and refers to a DNA or RNA chain longer than a certain length, and more specifically, refers to a polynucleotide fragment encoding the glycosyltransferase B (UGT-B).

[0041] The polynucleotide encoding glycosyltransferase B (UGT-B) of the present application may comprise a nucleotide sequence encoding the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3. As an example of the present application, the polynucleotide may have or comprise the sequence represented by SEQ ID NO: 6, SEQ ID NO: 7, or SEQ ID NO: 8. Furthermore, the polynucleotide may consist of the sequence represented by SEQ ID NO: 6, SEQ ID NO: 7, or SEQ ID NO: 8, or may essentially consist of the sequence represented by SEQ ID NO: 6, SEQ ID NO: 7, or SEQ ID NO: 8.

[0042] The polynucleotide of the present application may have various modifications in the coding region due to codon degeneracy or taking into consideration preferred codons in an organism in which the glycosyltransferase B (UGT-B) of the present application is to be expressed, as long as the amino acid sequence of the glycosyltransferase B (UGT-B) of the present application is not changed. Specifically, the polynucleotide of the present application has a base sequence that is 70% or more, 75% or more, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, and less than 100% homologous or identical to the sequence of SEQ ID NO:6, SEQ ID NO:7, or SEQ ID NO:8, or contains the above base sequence, or is composed of a base sequence that is 70% or more, 75% or more, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, and less than 100% homologous or identical to the sequence of SEQ ID NO:6, SEQ ID NO:7, or SEQ ID NO:8, or is substantially composed of the above base sequence, but is not limited to these.

[0043] Furthermore, the polynucleotide of the present application may be any sequence that hybridizes under stringent conditions with a probe prepared from a known gene sequence, for example, a complementary sequence to all or a part of the polynucleotide sequence of the present application. The term "stringent conditions" refers to conditions that allow specific hybridization between polynucleotides. Such conditions are specifically described in the literature (see Non-Patent Documents 11 and 12). For example, the conditions include conditions under which polynucleotides having high homology or identity, such as polynucleotides having a homology or identity of 70% or more, 75% or more, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more, hybridize with each other, but polynucleotides having lower homology or identity than that do not hybridize with each other, or conditions under which washing is performed once, specifically two to three times, at a salt concentration and temperature equivalent to normal Southern hybridization washing conditions of 60°C, 1 x SSC, 0.1% SDS, specifically 60°C, 0.1 x SSC, 0.1% SDS, more specifically 68°C, 0.1 x SSC, 0.1% SDS.

[0044] Hybridization requires that two nucleic acids have complementary sequences, even though mismatches between bases are possible depending on the stringency of hybridization. "Complementary" is used to describe the relationship between nucleotide bases that can hybridize with each other. For example, in DNA, adenine is complementary to thymine, and cytosine is complementary to guanine. Thus, the polynucleotides of the present application may include isolated nucleic acid fragments that are complementary to the entire sequence, as well as substantially similar nucleic acid sequences.

[0045] Specifically, polynucleotides having homology or identity to the polynucleotides of the present application can be detected using the hybridization conditions described above, in which the hybridization step is performed at a Tm value of 55° C. The Tm value may be, but is not limited to, 60° C., 63° C., or 65° C., and may be appropriately adjusted by those skilled in the art depending on the purpose.

[0046] The appropriate stringency for hybridizing the polynucleotides depends on the length of the polynucleotides and the degree of complementation, variables known in the art (eg, Non-Patent Document 11).

[0047] In one embodiment of the present application, the glucose-linked nucleotide diphosphate is prepared by reacting sucrose with nucleotide diphosphate in the presence of sucrose synthase, but is not limited thereto.

[0048] The term "sucrose synthase" in the present application plays a role in the metabolism of a plant body in reversibly transferring glucose bound to a nucleotide diphosphate to fructose to produce sucrose, and in the present application, exhibits the activity of reacting sucrose with nucleotide diphosphate in the pH range of 5 to 10 and separating the sucrose into a nucleotide diphosphate bound to a glucose and fructose.

[0049] The sucrose synthase is derived from rice, corn, wheat, bamboo, Arabidopsis, turfgrass, barley, sorghum, or potato, preferably from rice, corn, wheat, or barley, and more preferably from rice, particularly Oryza sativa. The sucrose synthase may be produced from recombinant Escherichia coli, Bacillus, yeast, Corynebacterium, or Agrobacterium transformed with a vector having a sucrose synthase gene, or produced from the Escherichia coli or the like and further purified, or a sucrose synthase known in the art, or a commercially available sucrose synthase, but is not limited thereto.

[0050] Specifically, the sucrose synthase of the present application may have the amino acid sequence shown in SEQ ID NO:5, may contain the amino acid sequence, may essentially consist of the amino acid sequence, or may consist of the amino acid sequence.

[0051] The sucrose may be any sucrose that can act as a substrate for sucrose synthase to provide glucose to nucleotide diphosphate, such as, but not limited to, raw sugar or sugar.

[0052] In the present application, the nucleotide diphosphate may be a purine nucleotide or a pyrimidine nucleotide, with uridine diphosphate being preferred, but not limited thereto.

[0053] The glucose-linked nucleotide diphosphate may be reacted with rebaudioside A to produce rebaudioside D by a glycosyltransferase B (UGT-B) of the present application.

[0054] In one non-limiting example of the present application, rebaudioside A is prepared by reacting a glucose-linked nucleotide diphosphate with stevioside in the presence of glycosyltransferase A (UGT-A).

[0055] The glycosyltransferase A (UGT-A) may react a glucose-linked nucleotide diphosphate with stevioside to produce rebaudioside A.

[0056] The glycosyltransferase A (UGT-A) may be a glycosyltransferase derived from Oryza sativa, Stevia rebaudiana Bertoni, Bambusa oldhamii, Brachypodium distachyon, Hordeum vulgare, Sorghum bicolor, Zea mays, or Arabidopsis thaliana. The glycosyltransferase is preferably a glycosyltransferase derived from Oryza sativa, Stevia rebaudiana Bertoni, or Bambusa oldhamii. The glycosyltransferase is more preferably a glycosyltransferase derived from Stevia rebaudiana Bertoni. The glycosyltransferase A (UGT-A) may be one produced from recombinant Escherichia coli, Bacillus, yeast, Corynebacterium, or Agrobacterium transformed with a vector having a glycosyltransferase gene, one produced from the Escherichia coli or the like and further purified, one known in the art, or one commercially available, but is not limited thereto.

[0057] Specifically, the glycosyltransferase A (UGT-A) of the present application may have the amino acid sequence shown in SEQ ID NO: 4, may contain the amino acid sequence, may essentially consist of the amino acid sequence, or may consist of the amino acid sequence.

[0058] The stevioside is a Stevia rebaudiana hot water or ethanol aqueous solution extract, or a purified product thereof, or a by-product of rebaudioside A production from the extract, and the stevioside content is 10% by weight or more, preferably 50% by weight or more, more preferably 70% by weight or more, and even more preferably 80% by weight or more of the total weight of steviol glycosides, but is not limited thereto.

[0059] In one embodiment of the present application, the rebaudioside D is prepared as shown in Reaction Scheme 1, but is not limited thereto.

[0060] [Reaction Scheme 1] TIFF2024540897000002.tif17127

[0061] Specifically, the production method may be carried out continuously in the same reaction system.

[0062] By "same reaction system" in this application is meant that reactions occur sequentially in one reaction system or reaction system.

[0063] The production method of the present application provides a continuous reaction system for synthesizing rebaudioside A in high yield by specifically binding one glucose to the C-3' position of 13-O-glucose of stevioside according to Reaction Scheme 1, and synthesizing rebaudioside D from rebaudioside A.

[0064] In one embodiment of the present application, the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, and further produces an isomer of rebaudioside D, but is not limited thereto.

[0065] For example, the rebaudioside D has the following structural formula, but is not limited thereto:

[0066] [ka]

[0067] Another aspect of the present application provides a method for producing rebaudioside M, comprising the steps of reacting a glucose-bound nucleotide diphosphate with rebaudioside A in the presence of glycosyltransferase B (UGT-B) to produce rebaudioside D, and reacting the rebaudioside D with a glucose-bound nucleotide diphosphate in the presence of glycosyltransferase A (UGT-A) to produce rebaudioside M, wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

[0068] The nucleotide diphosphate, glycosyltransferase B (UGT-B), rebaudioside A, and rebaudioside D are as described above.

[0069] In one embodiment of the present application, the glucose-linked nucleotide diphosphate is prepared by reacting sucrose with nucleotide diphosphate in the presence of sucrose synthase, as shown in Reaction Scheme 1, but is not limited thereto.

[0070] Specifically, the sucrose synthase of the present application may have the amino acid sequence shown in SEQ ID NO:5, may contain the amino acid sequence, may essentially consist of the amino acid sequence, or may consist of the amino acid sequence.

[0071] In one embodiment of the present application, rebaudioside A is prepared by reacting a glucose-linked nucleotide diphosphate with stevioside in the presence of glycosyltransferase A (UGT-A) as shown in Reaction Scheme 1, but is not limited thereto.

[0072] Specifically, the glycosyltransferase A (UGT-A) may have the amino acid sequence shown in SEQ ID NO: 4, may contain the amino acid sequence, may essentially consist of the amino acid sequence, or may consist of the amino acid sequence.

[0073] The glycosyltransferase A (UGT-A) of the present application may react a glucose-linked nucleotide diphosphate with rebaudioside D to produce rebaudioside M.

[0074] Specifically, the glycosyltransferase A (UGT-A) of the present application may have the amino acid sequence shown in SEQ ID NO: 4, may contain the amino acid sequence, may essentially consist of the amino acid sequence, or may consist of the amino acid sequence.

[0075] In one embodiment of the present application, the rebaudioside M is prepared as shown in Reaction Scheme 2, but is not limited thereto.

[0076] [Reaction Scheme 2] TIFF2024540897000004.tif14143

[0077] Specifically, the production method may be carried out continuously in the same reaction system.

[0078] The production method of the present application provides a continuous reaction system for synthesizing rebaudioside A from stevioside in high yield, synthesizing rebaudioside D from rebaudioside A, and synthesizing rebaudioside M from rebaudioside D, according to Reaction Scheme 2.

[0079] Therefore, the production method of the present application uses easily available and inexpensive raw materials such as stevioside and rebaudioside A, and can convert bitter components such as stevioside and rebaudioside A contained in stevia extract into rebaudioside D and rebaudioside M, which are palatable components, and is therefore useful for producing a stevia sweetener with good sweetness quality.

[0080] In one embodiment of the present application, the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, and further produces an isomer of rebaudioside M, but is not limited thereto.

[0081] For example, the rebaudioside M has the following structural formula, but is not limited thereto:

[0082] [ka]

[0083] Yet another aspect of the present application provides a method for producing rebaudioside D from rebaudioside A, the method comprising the step of producing rebaudioside D by reacting sucrose, nucleotide diphosphate, rebaudioside A, sucrose synthase, and glycosyltransferase B (UGT-B) in a reaction system, wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

[0084] The sucrose, nucleotide diphosphate, rebaudioside A, sucrose synthase, glycosyltransferase B (UGT-B), rebaudioside D, and the same reaction system are as described above.

[0085] In one embodiment of the present application, the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, and further produces an isomer of rebaudioside D, but is not limited thereto.

[0086] Yet another aspect of the present application provides a method for producing rebaudioside M from rebaudioside A, the method comprising the step of producing rebaudioside M by reacting sucrose, nucleotide diphosphate, rebaudioside A, rebaudioside D, sucrose synthase, glycosyltransferase A (UGT-A) and glycosyltransferase B (UGT-B) in a single reaction system, wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

[0087] The sucrose, nucleotide diphosphate, rebaudioside A, rebaudioside D, sucrose synthase, glycosyltransferase A (UGT-A), glycosyltransferase B (UGT-B), identical reaction system, and rebaudioside M are as described above.

[0088] Specifically, the glycosyltransferase A (UGT-A) is a protein consisting of the amino acid sequence shown in SEQ ID NO: 4, but is not limited thereto.

[0089] In one embodiment of the present application, the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, and further produces an isomer of rebaudioside M, but is not limited thereto.

[0090] Yet another aspect of the present application provides a composition for producing rebaudioside D, comprising glycosyltransferase B (UGT-B), wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

[0091] The glycosyltransferase B (UGT-B) and rebaudioside D are as described above.

[0092] In one embodiment of the present application, the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, and the rebaudioside D is at least one selected from the group consisting of rebaudioside D and an isomer of rebaudioside D, but is not limited thereto.

[0093] Yet another aspect of the present application provides a composition for producing rebaudioside M, comprising glycosyltransferase A (UGT-A) and glycosyltransferase B (UGT-B), wherein the glycosyltransferase A (UGT-A) is a protein consisting of the amino acid sequence represented by SEQ ID NO:4, and the glycosyltransferase B (UGT-B) is at least one protein selected from the group consisting of proteins consisting of the amino acid sequences represented by SEQ ID NOs:1 to 3.

[0094] The glycosyltransferase A (UGT-A), glycosyltransferase B (UGT-B), and rebaudioside M are as described above.

[0095] In one embodiment of the present application, the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, and the rebaudioside M is at least one selected from the group consisting of rebaudioside M and an isomer of rebaudioside M, but is not limited thereto.

[0096] The composition of the present application may further contain any suitable excipient that is commonly used in compositions for producing amino acids, including, but not limited to, preservatives, wetting agents, dispersing agents, suspending agents, buffers, stabilizers, isotonicity agents, etc.

[0097] Yet another aspect of the present application provides a use of glycosyltransferase B (UGT-B), which is at least one protein selected from the group consisting of proteins having the amino acid sequences shown in SEQ ID NOs: 1 to 3, as a glycosyltransferase that converts rebaudioside A to rebaudioside D.

[0098] The glycosyltransferase A (UGT-A), glycosyltransferase B (UGT-B), rebaudioside A, rebaudioside M, and the like are as described above. This application EXAMPLES

[0099] The present application will be described in more detail below with reference to examples. However, these examples are merely preferred embodiments illustrating the present application, and the present application is not limited thereto. Note that technical matters not described in this specification are fully understood and easily implemented by a skilled engineer in the technical field of the present application or a similar technical field. EXAMPLES

[0100] Culture conditions A polynucleotide encoding the glycosyltransferase B (UGT-B) of the present application was introduced into a recombinant microorganism to produce the recombinant microorganism, which was then expressed and used in the reaction. The culture conditions for the recombinant microorganism were as follows.

[0101] Example 1-1. Culture conditions for E. coli The recombinant E. coli was inoculated into a test tube containing 5 ml of LB medium containing kanamycin at a concentration of 50 μg / ml, and the seed bacteria was cultured in an incubator at 37 ° C until the absorbance at 600 nm reached 2.0. The culture solution in which the seed bacteria was cultured was added to a flask containing 500 ml of LB medium containing kanamycin at a concentration of 50 μg / ml, and main culture was performed. In addition, when the absorbance at 600 nm reached 0.4, 0.1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) was added to induce large-scale expression of the enzymes. In the above process, the stirring speed was adjusted to 180 rpm and the culture temperature was maintained at 37 ° C., and after the addition of IPTG, the culture was performed at a stirring speed of 120 rpm.

[0102] Example 1-2. Culture conditions for Corynebacterium The recombinant Corynebacterium was inoculated at an initial concentration of OD600 = 0.1 into a medium (Bacto-Trypton 10g / L, Bacto-yeast extract 5g / L, NaCl 5g / L, Soytone 5g / L) containing 10μg / ml kanamycin, and cultured at 30℃ for 24 hours to induce enzyme expression. The culture obtained as described above was inoculated at OD600 = 0.6 into a fermenter containing a medium (glucose 80g / L, soytone 20g / L, (NH4)2SO4 10g / L, KH2PO4 1.2g / L, MgSO4 1.4g / L) containing 10μg / ml kanamycin, and cultured at 30℃ for 24 hours. EXAMPLES

[0103] Measurement of Enzyme Activity of Glycosyltransferase B (UGT-B) on Rebaudioside A Raw Material Example 2-1. Purification of glycosyltransferase B (UGT-B) The glycosyltransferase B (UGT-B; SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3) of the present application, which converts rebaudioside A to rebaudioside D, was prepared by preparing a recombinant plasmid (vector-pET28a) containing a gene (SEQ ID NO: 6, SEQ ID NO: 7, or SEQ ID NO: 8) encoding the glycosyltransferase B of the present application, cloning the plasmid into Escherichia coli BL21(DE3) to mass-express each enzyme, and then purifying the enzyme for use.

[0104] Specifically, the recombinant strain BL21(DE3) was inoculated into a test tube containing 5 ml of LB medium, and the seed bacteria was cultured in an incubator at 37°C until the absorbance at 600 nm reached 2.0. The culture solution in which the seed bacteria was cultured was added to a flask containing 500 ml of LB medium, and main culture was performed. When the absorbance at 600 nm reached 0.4, 0.1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) was added to induce large-scale expression of the enzyme. In the above process, the stirring speed was adjusted to 180 rpm and the culture temperature was maintained at 37°C, and after the addition of IPTG, the culture was performed at a stirring speed of 120 rpm and a culture temperature of 16°C. As described above, the culture solution of the transformed strain was centrifuged at 6000×g and 4°C for 20 minutes, and only the cell supernatant was separated as the enzyme solution. In order to accurately grasp the properties of the enzyme, it was purified using a Ni-NTA superflow column.

[0105] The enzymes overexpressed using the recombinant plasmids containing SEQ ID NO:6, SEQ ID NO:7, or SEQ ID NO:8 were named UGT-B_6, UGT-B_7, and UGT-B_8.

[0106] On the other hand, the recombinant Corynebacterium was inoculated at an initial concentration of OD600 = 0.1 into a medium (Bacto-Trypton 10g / L, Bacto-yeast extract 5g / L, NaCl 5g / L, Soytone 5g / L) containing 10μg / ml kanamycin, and cultured at 30℃ for 24 hours to induce enzyme expression. The culture obtained as described above was inoculated at OD600 = 0.6 into a fermenter containing a medium (glucose 80g / L, soytone 20g / L, (NH4)2SO4 10g / L, KH2PO4 1.2g / L, MgSO4 1.4g / L) containing 10μg / ml kanamycin, and cultured at 30℃ for 24 hours.

[0107] Example 2-2. Measurement of enzyme activity of glycosyltransferase B (UGT-B) on rebaudioside A raw material Using each of the enzymes prepared in Example 2-1, the enzymatic activity of glycosyltransferase B (UGT-B) for the raw material rebaudioside A was measured.

[0108] Specifically, the raw material used in the enzyme reaction was rebaudioside A (Daepyeong Co., Ltd.), which was dissolved in water to a concentration of 2 mM. Using each enzyme expressed in a microorganism prepared in Example 2-1, the reaction was carried out at 37 degrees for 16 hours, and then analyzed by HPLC. The aqueous solution of the raw material contained 2 mM UDP-glucose or UDP (Uridine-diphosphate).

[0109] The HPLC analysis conditions were as follows. Detector wavelength: 210nm Flow rate: 1ml / min Sample injection volume: 10μl ·Column:Capcell pak C18 MG II(Shiseido, 250×4.6mm, particle size:5μm) Solvent: Acetonitrile 30%

[0110] The measurement results are shown in Table 1 and Figures 1 to 3.

[0111] [Table 1]

[0112] As shown in Table 1 and FIGS. 1 to 3, it was confirmed that rebaudioside A was converted to rebaudioside D by glycosyltransferase B (UGT-B_6 and UGT-B_8) of the present application, and that rebaudioside A was converted to rebaudioside M isomers, rebaudioside D isomers, and rebaudioside D by glycosyltransferase (UGT-B_7) of the present application. EXAMPLES

[0113] Measurement of the enzyme activities of glycosyltransferase A (UGT-A) and glycosyltransferase B (UGT-B) on stevioside raw materials Glycosyltransferase A (UGT-A) and sucrose synthase were purified according to the method described in the prior art (Patent Document 2) and used. Their sequences are shown in SEQ ID NO: 4 and SEQ ID NO: 5, respectively.

[0114] Using the glycosyltransferase A (UGT-A), the sucrose synthase, and each glycosyltransferase B (UGT-B) prepared in Example 2-1, the enzymatic activity of glycosyltransferase A (UGT-A) and glycosyltransferase B (UGT-B) against stevioside raw material was measured.

[0115] Specifically, 2 mM stevioside (Haigen) and 50 mM sugar (CJ Dailjedang) aqueous solutions were used as raw materials for the enzyme reaction. The glycosyltransferase A (UGT-A), sucrose synthase, and each glycosyltransferase B (UGT-B) prepared in Example 2-1 expressed in a microorganism were used for the reaction at 37°C for 24 hours, and then analyzed by HPLC. The aqueous solution of the raw materials contained 2 mM UDP-glucose or UDP (Uridine-diphosphate).

[0116] The HPLC analysis conditions were as follows. Detector wavelength: 210nm Flow rate: 1ml / min Sample injection volume: 10μl ·Column:Capcell pak C18 MG II(Shiseido, 250×4.6mm, particle size:5μm) Solvent: Acetonitrile 30%

[0117] The measurement results are shown in Table 2 and FIGS.

[0118] [Table 2]

[0119] As shown in Table 2 and FIGS. 4 to 6, it was confirmed that stevioside was converted to rebaudioside M isomers, rebaudioside D, rebaudioside M, rebaudioside I, and rebaudioside A at a molar concentration of 100%. EXAMPLES

[0120] Measurement of Enzyme Activity of Glycosyltransferase A (UGT-A) on Rebaudioside D Raw Materials The conversion rate of rebaudioside D to rebaudioside M was measured using glycosyltransferase A (UGT-A) from Example 3.

[0121] Specifically, rebaudioside D (Haigen) was dissolved in water to a concentration of 1 mM as the raw material for the enzyme reaction. The reaction was carried out at 37°C for 16 hours using the glycosyltransferase A (UGT-A) expressed in a microorganism, and then analyzed by HPLC. The raw material aqueous solution contained 2 mM UDP-glucose or UDP (Uridine-diphosphate).

[0122] The HPLC analysis conditions were as follows. Detector wavelength: 210nm Flow rate: 1ml / min Sample injection volume: 10μl ·Column:Capcell pak C18 MG II(Shiseido, 250×4.6mm, particle size:5μm) Solvent: Acetonitrile 30%

[0123] The measurement results are shown in Figure 7.

[0124] As shown in FIG. 7, it was confirmed that rebaudioside D was almost entirely converted to rebaudioside M by glycosyltransferase A of the present application. EXAMPLES

[0125] Analysis of Rebaudioside D Isomers and Rebaudioside M Isomers by Liquid Chromatography-Mass Spectrometry (LC-MS / MS) To confirm whether the compounds converted in Example 2 and Example 3 are rebaudioside D isomers or rebaudioside M isomers, the rebaudioside D isomers and rebaudioside M isomers converted in Example 2 and Example 3 were compared with rebaudioside D and rebaudioside M, respectively, using liquid chromatography mass spectrometry (LC-MS / MS) analysis.

[0126] Specifically, Acquity UPLC (Waters) and Xe-vo G2-XS Q-Tof mass spectrometer were used. The LC-MS / MS analysis conditions are shown in Table 3, the elution conditions are shown in Table 4, and the MS conditions are shown in Table 5.

[0127] [Table 3]

[0128] [Table 4]

[0129] [Table 5]

[0130] As a result, as shown in Figures 8 and 9, a comparison of the RebD Standard and the fractionated unknown peak 1 revealed that the RebD standard and unknown peak 1 have the same molecular weight and the MSMS fragments match, but the peak retention times are different, confirming that unknown peak 1 is an isomer of RebD.

[0131] As shown in Figures 10 and 11, a comparison of the RebM Standard and the fractionated unknown peak 2 revealed that the RebM standard and unknown peak 2 have the same molecular weight and the MSMS fragments match, but the peak retention times are different, confirming that unknown peak 2 is an isomer of RebM.

[0132] From the above description, a person skilled in the art to which the present application pertains will understand that the present application can be implemented in other specific forms without changing its technical ideas or essential features. It should be understood that the above examples are merely illustrative and not limiting. This application should be interpreted as including all modifications or alterations derived from the meaning and scope of the claims and their equivalent concepts, rather than the specification.

Claims

1. reacting a glucose-linked nucleotide diphosphate with rebaudioside A in the presence of glycosyltransferase B (UGT-B) to produce rebaudioside D; The method for producing rebaudioside D, wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

2. The method according to claim 1 , wherein the glucose-linked nucleotide diphosphate is produced by reacting sucrose with nucleotide diphosphate in the presence of sucrose synthase.

3. 2. The method of claim 1, wherein the rebaudioside A is prepared by reacting a glucose-linked nucleotide diphosphate with stevioside in the presence of glycosyltransferase A (UGT-A).

4. The method of claim 2 , wherein the sucrose synthase is a protein consisting of the amino acid sequence represented by SEQ ID NO:

5.

5. The method according to claim 3, wherein the glycosyltransferase A (UGT-A) is a protein consisting of the amino acid sequence represented by SEQ ID NO:

4.

6. 2. The method of claim 1, wherein the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 2 and further produces an isomer of rebaudioside D.

7. The method according to any one of claims 1 to 6, wherein the method is carried out continuously in the same reaction system.

8. reacting a glucose-linked nucleotide diphosphate with rebaudioside A in the presence of glycosyltransferase B (UGT-B) to produce rebaudioside D; reacting the rebaudioside D with a glucose-linked nucleotide diphosphate in the presence of glycosyltransferase A (UGT-A) to produce rebaudioside M; The method for producing rebaudioside M, wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

9. The method according to claim 8, wherein the glycosyltransferase A (UGT-A) is a protein consisting of the amino acid sequence represented by SEQ ID NO:

4.

10. The method according to claim 8, wherein the glucose-linked nucleotide diphosphate is produced by reacting sucrose with nucleotide diphosphate in the presence of sucrose synthase.

11. 9. The method of claim 8, wherein the rebaudioside A is prepared by reacting a glucose-linked nucleotide diphosphate with stevioside in the presence of glycosyltransferase A (UGT-A).

12. The method of claim 10, wherein the sucrose synthase is a protein consisting of the amino acid sequence represented by SEQ ID NO:

5.

13. The method according to claim 11, wherein the glycosyltransferase A (UGT-A) is a protein consisting of the amino acid sequence represented by SEQ ID NO:

4.

14. 9. The method of claim 8, wherein the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 2 and further produces an isomer of rebaudioside M.

15. The method according to any one of claims 8 to 14, wherein the method is carried out continuously in the same reaction system.

16. comprising a step of reacting sucrose, nucleotide diphosphate, rebaudioside A, sucrose synthase and glycosyltransferase B (UGT-B) in a single reaction system to produce rebaudioside D; The method for producing rebaudioside D from rebaudioside A, wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

17. 17. The method for producing rebaudioside D from rebaudioside A according to claim 16, wherein the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 2 and further produces an isomer of rebaudioside D.

18. comprising a step of reacting sucrose, nucleotide diphosphate, rebaudioside A, rebaudioside D, sucrose synthase, glycosyltransferase A (UGT-A) and glycosyltransferase B (UGT-B) in a single reaction system to produce rebaudioside M; The method for producing rebaudioside M from rebaudioside A, wherein the glycosyltransferase B is at least one protein selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

19. The method for producing rebaudioside M from rebaudioside A according to claim 18, wherein the glycosyltransferase A (UGT-A) is a protein consisting of the amino acid sequence represented by SEQ ID NO:

4.

20. 20. The method for producing rebaudioside M from rebaudioside A according to claim 18, wherein the glycosyltransferase B is a protein consisting of the amino acid sequence represented by SEQ ID NO: 2 and further produces an isomer of rebaudioside M.

21. A composition for producing rebaudioside D, comprising at least one type of glycosyltransferase B (UGT-B) selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3.

22. 22. The composition for producing rebaudioside D according to claim 21, wherein the glycosyltransferase B is a protein consisting of an amino acid sequence represented by SEQ ID NO: 2, and the rebaudioside D is at least one selected from the group consisting of rebaudioside D and an isomer of rebaudioside D.

23. At least one type of glycosyltransferase B (UGT-B) selected from the group consisting of proteins having the amino acid sequences represented by SEQ ID NOs: 1 to 3; A composition for producing rebaudioside M, comprising glycosyltransferase A (UGT-A), a protein having an amino acid sequence represented by SEQ ID NO:

4.

24. 24. The composition for producing rebaudioside M according to claim 23, wherein the glycosyltransferase B is a protein consisting of an amino acid sequence represented by SEQ ID NO: 2, and the rebaudioside M is at least one selected from the group consisting of rebaudioside M and an isomer of rebaudioside M.

Citation Information

Patent Citations

  • Glycosyltransferase StUGT capable of catalyzing rebaudioside A to generate rebaudioside D

    CN112760302A

  • Method for producing rebaudioside a from stevioside

    JP2016508378A

  • Preparation of rebaudioside m in a single reaction vessel

    WO2017031424A1

  • Method for manufacturing rebaudioside a from stevioside

    KR101404728B1

  • Method for preparing rebaudioside a from stevioside

    WO2014133248A1